The role of G3BP granules in mRNA translation regulation and cell adaptation to exogenous stress
G3BP颗粒在mRNA翻译调控和细胞对外源应激适应中的作用
基本信息
- 批准号:10313131
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alpha GranuleAmyotrophic Lateral SclerosisBindingBinding ProteinsBiological AssayBiological ProcessBiological TestingCell DeathCell SurvivalCellsCellular StressCessation of lifeChronic stressCoupledCytoplasmCytoplasmic GranulesDataDisease ProgressionDissociationEukaryotic CellExhibitsFloorFluorescence MicroscopyFluorescence Recovery After PhotobleachingG3BP1 geneGenetic TranslationHumanKineticsLabelLaboratoriesLinkLiquid substanceMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMembraneMessenger RNAMicrofluidicsModelingOrganellesPathologicPathologyPeptide Initiation FactorsPhasePhosphorylationPhysiologicalPhysiologyPolyribosomesProcessPropertyPropidium DiiodideProtein IsoformsProteinsRNARNA StabilityRNA-Binding ProteinsRecoveryRegulationRoleSH3 DomainsSolidStressStructureTechniquesTestingTherapeuticTranscriptTranslatingTranslationsUltraviolet Raysacute stressbasebiological adaptation to stressbiophysical propertiesdesignendoplasmic reticulum stressexperimental studyinsightmacromoleculeoptogeneticsras GTPase-Activating Proteinsrecruitstress granuletranscriptome sequencingtranslation factor
项目摘要
Project Summary/Abstract
G3BP stress granules (SGs) are a component of the eukaryotic stress response. They are membrane-less
organelles that form as a consequence of eIF2⍺ phosphorylation and global translation inhibition. The role of
G3BP granules during cellular stress is not completely understood. They are composed of untranslated mRNAs
and factors from the translational machinery leading to the model that G3BP SGs inhibit translation through the
sequestration of macromolecules from the bulk cytoplasm. Furthermore, the biological function of G3BP granules
may be regulated by their liquid-like properties. This feature may allow G3BP SGs to interact dynamically with
the bulk cytoplasm and to reversibly dissociate when cells recover from stress. Moreover, it has been proposed
that SG transitioning to solid-like structure during prolonged stress is detrimental to survival. However, detailed
characterization of G3BP granules liquid stability and their role in cell survival during stress response is still
lacking. I hypothesize that G3BP granules protect mammalian cells against stress by regulating translation of
mRNAs and retaining a stable liquid-like phase in the bulk cytoplasm. To test the direct role of G3BP granules
in translation inhibition, in my aim 1, I will characterize the protein and RNA composition of G3BP granules under
exogenous stress in human cells through APEX2-proximity labeling coupled to RNA sequencing and Mass
Spectrometry. Furthermore, to decouple the effects that stress induction may have on SG composition, I will
characterize the protein/RNA molecules associated to SGs induced with optogenetics. Then, I will perform the
Transcript Isoforms in Polysomes sequencing (TrIP-seq) technique, which characterizes the abundance of
mRNAs associated to polysomes, to define the relationship between SG recruitment of mRNAs and their
translation. To test the biological function of G3BP SG biophysical properties to cell survival, in my aim 2, I will
study the liquid stability and reversibility of G3BP granule formation under acute and chronic stress with a
microfluidics-based fluorescence microscopy approach currently developed in the Floor and Wittmann
laboratories at UCSF. Then, I will evaluate transitions in the material properties of G3BP granules by performing
fluorescence recovery after photobleaching (FRAP) experiments. Finally, I will determine the viability of cells
through a propidium iodide-based assay to elucidate the role of liquid stability and kinetics of granule formation
to survival from stress. In summary, this project will provide insights into the physiological role of G3BP granules
to survival during the stress response and recovery and the biological function of their liquid stability in promoting
cellular adaptability under exogenous stress.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose Liboy其他文献
Jose Liboy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose Liboy', 18)}}的其他基金
The role of G3BP granules in mRNA translation regulation and cell adaptation to exogenous stress
G3BP颗粒在mRNA翻译调控和细胞对外源应激适应中的作用
- 批准号:
10460974 - 财政年份:2021
- 资助金额:
$ 4.2万 - 项目类别:
The role of G3BP granules in mRNA translation regulation and cell adaptation to exogenous stress
G3BP颗粒在mRNA翻译调控和细胞对外源应激适应中的作用
- 批准号:
10677026 - 财政年份:2021
- 资助金额:
$ 4.2万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 4.2万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 4.2万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 4.2万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Standard Grant
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Fellowship
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 4.2万 - 项目类别:
Operating Grants